Last reviewed · How we verify
Chromium Tripicolinate (CHROMIUM PICOLINATE)
Chromium Tripicolinate (generic name: CHROMIUM PICOLINATE) is a drug. It is currently in discontinued development.
Chromium Picolinate works by facilitating the uptake of glucose into cells, potentially improving insulin sensitivity and glucose metabolism.
Chromium Picolinate, also known as Chromium Tripicolinate, is a small molecule compound that has been developed for potential therapeutic use. However, its exact target and mechanism of action are currently unknown. It is not FDA-approved for any indications, and its commercial status, patent status, and availability of generic manufacturers are also unclear. Further research is needed to determine its efficacy and safety profile. As a result, it is not currently available for clinical use.
At a glance
| Generic name | CHROMIUM PICOLINATE |
|---|---|
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | discontinued |
Mechanism of action
Think of it like a key that unlocks a door. In this case, the door is the cell membrane, and Chromium Picolinate is the key that helps glucose molecules enter the cell. This can help improve how well the body uses insulin, a hormone that regulates blood sugar levels.
Approved indications
Common side effects
- Cerebral venous thrombosis
- Thalamic infarction
- Slow response to stimuli
- Bradyphrenia
- Fatigue
Key clinical trials
- Hunger Perception and Weight-Related Outcomes Following Use of a Leptin-Supporting Dietary Supplement (NA)
- Efficacy of Chromium Picolinate in Reducing Acanthosis Nigricans Severity in Adolescents With Insulin Resistance (NA)
- A Clinical Trial to Investigate the Safety and Efficacy of MB-1 on Metabolic Health in Overweight and Obese Adults (NA)
- Preventive Nutritional Supplements for Preclinical Pathologies (NA)
- Effect of a Food Supplement on Blood Glucose Levels in Patients With Impaired Glucose Values (NA)
- Effect of a Food Supplement on Glycemic Parameters in Patients With Impaired Glucose Metabolism (NA)
- OXXYNEA® GS: Study for Glycaemia Management (NA)
- A Study to Evaluate a Postbiotic in Supporting Weight Loss and Metabolic Health (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Chromium Tripicolinate CI brief — competitive landscape report
- Chromium Tripicolinate updates RSS · CI watch RSS
Frequently asked questions about Chromium Tripicolinate
What is Chromium Tripicolinate?
How does Chromium Tripicolinate work?
What is the generic name of Chromium Tripicolinate?
What development phase is Chromium Tripicolinate in?
What are the side effects of Chromium Tripicolinate?
Related
- Therapeutic area: All drugs in Metabolic
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing